Buddy Carter U.S. House of Representatives from Georgia's 1st district | Official U.S. House Headshot
Buddy Carter U.S. House of Representatives from Georgia's 1st district | Official U.S. House Headshot
Rep. Earl L. "Buddy" Carter introduced the FDA Modernization Act 3.0 in Washington, D.C. The bill, backed by Reps. Nanette Barragán, Vern Buchanan, Rosa DeLauro, Diana Harshbarger, and Troy Carter, aims to reduce animal testing in drug development. It requires the FDA to fully implement the Modernization Act 2.0, enacted in 2022, to promote non-animal testing methods for developing patient treatments.
“It is inhumane to rely solely on animal testing of medical products when other, harmless methods exist that are more predictive of human outcomes. The FDA Modernization Act 2.0, and recent actions by the Trump administration, have paved the way for modernizing FDA’s testing methods. This bill will put these wins into practice, accelerating innovation and getting safer, more effective drugs to market quickly by cutting unnecessary red tape,” said Rep. Buddy Carter.
Reps. Vern Buchanan and Diana Harshbarger voiced support for the initiative. Buchanan remarked, “The FDA Modernization Act of 2021 was a monumental win that will streamline drug development and spur innovation without having to sacrifice at the expense of animal welfare.”
Harshbarger noted, “The FDA’s outdated animal testing rules are harming animals, hurting patients, and stalling medical innovation. The FDA Modernization Act 3.0 will cut burdensome red tape to allow drug manufacturers to use modern and more humane alternatives to improve safety for animals and patients alike. As a compound pharmacist for more than 30 years, I understand that ensuring East Tennesseans have affordable access to safe medicines is of the utmost priority, and this bill is a step toward delivering safe medicines in a more humane way.”
Rep. Troy A. Carter, Sr. added, “This bill will transform drug development for the 21st century. By requiring full implementation of the FDA Modernization Act 2.0, this legislation ensures that advanced, human-based testing methods are actively adopted in the drug development process. It’s a win for patients, a win for innovation, and a win for animal welfare. I’m proud to be join this bipartisan measure to accelerate safer, more humane, and more effective medical breakthroughs.”
The bill is available for public review.
Alerts Sign-up